Export 197 results:
Filters: Author is Di Paolo, Thérèse [Clear All Filters]
Androgens and Parkinson's Disease: A Review of Human Studies and Animal Models. Androg Clin Res Ther. 2021;2(1):294-303..
Effect of sex and gonadectomy on brain MPTP toxicity and response to dutasteride treatment in mice. Neuropharmacology. 2021;201:108784..
Evidence for Sprouting of Dopamine and Serotonin Axons in the Pallidum of Parkinsonian Monkeys. Front Neuroanat. 2018;12:38..
Membrane cholesterol removal and replenishment affect rat and monkey brain monoamine transporters. Neuropharmacology. 2018;133:289-306..
An mGlu4-Positive Allosteric Modulator Alleviates Parkinsonism in Primates. Mov Disord. 2018;33(10):1619-1631..
The plasmalogen precursor analog PPI-1011 reduces the development of L-DOPA-induced dyskinesias in de novo MPTP monkeys. Behav Brain Res. 2018;337:183-185..
Repurposing sex steroids and related drugs as potential treatment for Parkinson's disease. Neuropharmacology. 2018;..
Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors. Psychoneuroendocrinology. 2018;91:95-104..
Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice. J Steroid Biochem Mol Biol. 2017;174:242-256..
Effects of progesterone administered after MPTP on dopaminergic neurons of male mice. Neuropharmacology. 2017;117:209-218..
Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research. Neuropharmacology. 2017;115:166-179..
Non-human primate models of PD to test novel therapies. J Neural Transm (Vienna). 2017;..
Plasmalogen precursor mitigates striatal dopamine loss in MPTP mice. Brain Res. 2017;1674:70-76..
Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients. Biochem Pharmacol. 2016;109:62-9..
Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments. Parkinsons Dis. 2016;2016:6762528..
Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease. Neurosci Biobehav Rev. 2016;67:79-88..
Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson's disease. Neurobiol Aging. 2016;48:61-71..
Neuroprotective Effect of Progesterone in MPTP-Treated Male Mice. Neuroendocrinology. 2016;103(3-4):300-14..
The number of striatal cholinergic interneurons expressing calretinin is increased in parkinsonian monkeys. Neurobiol Dis. 2016;95:46-53..
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia. Mov Disord. 2016;31(7):1049-54..
Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice. PLoS One. 2016;11(3):e0151020..
The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease. Neuropharmacology. 2015;97:86-94..
Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy. J Neurosurg. 2015;123(6):1383-93..
Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications. Neuropharmacology. 2015;99:356-68..